Researchers find potential drug for emerging Chikungunya virus

Oregon Health & Science University researchers and partners are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.

Related Keywords

India ,Alabama ,United States ,Brazil ,University Of Alabama At Birmingham ,California ,Guatemala ,Oregon ,Markt Heise ,Richard Whitley ,Us Centers For Disease ,Drug Administration ,Young ,Southern Research ,University Of North Carolina At Chapel Hill ,Oregon Health Science University ,University Of Colorado Denver ,Gene Therapy Institute ,Oregon Health ,Science University ,Gene Therapy ,North Carolina ,Chapel Hill ,Colorado Denver ,Disease Control ,Investigational New Drug ,Chikungunya ,Paxlovid ,Disease Control And Prevention ,Indian ,Us Centers ,Covid ,Us ,Us Food And Drug Administration ,Richard ,University Of North Carolina ,Europe ,Vaccine ,